An Insurance Re-Rating That Has Yet to Begin
Hidden gem in the financial landscape with improving fundamentals
We believe this specialty insurer is in a stronger position than most investors realize. Our team recently met with management to gain additional insight into the business. Recent quarterly results show a company that has moved past the challenges of 2023 and is now operating with far more consistency.
The noise from partner-specific loss activity and reserve adjustments in U.S. Programs has been addressed, and the platform is running with tighter controls and clearer performance. Canada continues to deliver stable underwriting results, U.S. fee income has expanded, and book value has climbed.
What makes this compelling is how little expectations have shifted.
The numbers have improved, yet estimates remain steady and the valuation still reflects a cautious stance. At the same time, the core of the business has become easier to follow across recent quarters with clearer signals emerging.
Canada provides reliable underwriting income, and the U.S. platform is now producing fee revenue that behaves more predictably as programs season. Together, they create a balanced earnings base and a clearer path into 2026.
Specialty insurers often see sentiment adjust after a period of steady execution that reframes the story. This one appears to be entering that phase, with fundamentals improving ahead of the market’s perception.
The upcoming section lays out the drivers behind this shift and presents our full Investment Thesis, detailed business analysis, valuation model, and our current and forward price targets.